|Articles|September 2, 2022

AJMC® in the Press, September 2, 2022

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by Men’s Health magazine cited a study published in the August 2015 issue of The American Journal of Managed Care^®. The study, “Opportunity Costs of Ambulatory Medical Care in the United States,” showed substantial time costs attributed to individuals and society for ambulatory medical care in the United States.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related to this article

October 19th, 2026

FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase 2 AZUR-1 results.

October 19th, 2026

Phentolamine 0.75% (Ryzumvi) won FDA approval for presbyopia based on the phase 3 VEGA-2 and VEGA-3 trials.

October 19th, 2026

Satralizumab, a first-in-class IL-6 receptor inhibitor, was approved for adults with thyroid eye disease based on the phase 3 SatraGO program.

October 19th, 2026

A review of 47 endometriosis guidelines found most came from high-income settings and diverged on biomarkers, repeat surgery, and fertility referral.

October 19th, 2026

The meeting covered several topics in eye care, including how artificial intelligence (AI) can play a part in eye care.

October 19th, 2026

A higher PNR is associated with lower odds of MASLD and advanced liver fibrosis, but further studies are needed to validate findings.

October 19th, 2026

Speakers at CHEST 2026 walked through the first CHEST guideline for non-CF adult bronchiectasis, including which preventive therapy to start first.

October 18th, 2026

On the opening day of CHEST 2026, the organization's flagship journal highlights a trio of key papers with practice-changing results for COPD.